Diethylstilbestrol Interactions
There are 159 drugs known to interact with diethylstilbestrol, along with 17 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 32 are major, 111 are moderate, and 16 are minor.
- View all 159 medications that may interact with diethylstilbestrol
- View diethylstilbestrol alcohol/food interactions (2)
- View diethylstilbestrol disease interactions (17)
Most frequently checked interactions
View interaction reports for diethylstilbestrol and the medicines listed below.
- Accutane (isotretinoin)
- Adalat CC (nifedipine)
- Advate (antihemophilic factor)
- Aleve (naproxen)
- Alimta (pemetrexed)
- Allegra (fexofenadine)
- Ambien (zolpidem)
- Aralen (chloroquine)
- Aspirin Low Strength (aspirin)
- Atromid-S (clofibrate)
- Baycol (cerivastatin)
- Beano (alpha-d-galactosidase)
- Belviq (lorcaserin)
- Benadryl (diphenhydramine)
- Bextra (valdecoxib)
- Brondelate (guaifenesin / oxtriphylline)
- Cardizem LA (diltiazem)
- Cialis (tadalafil)
- Cleocin (clindamycin)
- Co-trimoxazole (sulfamethoxazole / trimethoprim)
- Combivir (lamivudine / zidovudine)
- CoQ10 (ubiquinone)
- Cotellic (cobimetinib)
- Cylert (pemoline)
- Lasix (furosemide)
- OxyContin (oxycodone)
- Paracetamol (acetaminophen)
- Protonix (pantoprazole)
- Zofran (ondansetron)
- Zyrtec (cetirizine)
Diethylstilbestrol alcohol/food interactions
There are 2 alcohol/food interactions with diethylstilbestrol.
Diethylstilbestrol disease interactions
There are 17 disease interactions with diethylstilbestrol which include:
- abnormal vaginal bleeding
- carcinomas (estrogenic)
- hypercalcemia in breast cancer
- hypertension
- thromboembolism/cardiovascular
- hepatic neoplasms
- angioedema
- gallbladder disease
- hypercalcemia
- hyperlipidemia
- liver disease
- melasma
- depression
- fluid retention
- glucose intolerance
- retinal thrombosis
- thyroid function tests
Report options
QR code containing a link to this page
More about diethylstilbestrol
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
